KASSANDRA VANSTEENBERG: Open Payments
NPI 1558125534 · KENT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $558 · 2025 $140
Food & beverage: $140
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: REXULTI, AIRSUPRA, JARDIANCE, GEMTESA, XIFAXAN, TRELEGY ELLIPTA, SHINGRIX.
Industry payments across OH — which companies pay providers there.
